Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Mutations in dynamin 2 cause dominant centronuclear myopathy

Abstract

Autosomal dominant centronuclear myopathy is a rare congenital myopathy characterized by delayed motor milestones and muscular weakness. In 11 families affected by centronuclear myopathy, we identified recurrent and de novo missense mutations in the gene dynamin 2 (DNM2, 19p13.2), which encodes a protein involved in endocytosis and membrane trafficking, actin assembly and centrosome cohesion. The transfected mutants showed reduced labeling in the centrosome, suggesting that DNM2 mutations might cause centronuclear myopathy by interfering with centrosome function.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Localization of transfected DNM2 in fibroblasts and expression of DNM2 and α-tubulin in fibroblasts from individuals with CNM.

Similar content being viewed by others

References

  1. Spiro, A.J., Shy, G.M. & Gonatas, N.K. Arch. Neurol. 14, 1–14 (1966).

    Article  CAS  Google Scholar 

  2. Jeannet, P.-Y. et al. Neurology 62, 1484–1490 (2004).

    Article  Google Scholar 

  3. Fardeau, M. & Tomé, F.M. in Myology 2nd edn. (Engel, A.G., Franzini-Armstrong, C., eds.) 1500–1504 (McGraw-Hill, New York, 1994).

    Google Scholar 

  4. Laporte, J., Bedez, F., Bolino, A & Mandel, J.-L. Hum. Mol. Genet. 12, R285–R292 (2003).

    Article  CAS  Google Scholar 

  5. Cook, T.A., Urrutia, R. & McNiven, M.A. Proc. Natl. Acad. Sci. USA 91, 644–648 (1994).

    Article  CAS  Google Scholar 

  6. Praefcke, G.J. & McMahon, H.T. Nat. Rev. Mol. Cell Biol. 5, 133–147 (2004).

    Article  CAS  Google Scholar 

  7. Jones, S.M., Howell, K.E., Henley, J.R., Cao, H. & McNiven, M.A. Science 279, 573–577 (1998).

    Article  CAS  Google Scholar 

  8. Yoo, J., Jeong, M.J., Cho, H.J., Oh, E.S. & Han, M.Y. Biochem. Biophys. Res. Commun. 328, 424–431 (2005).

    Article  CAS  Google Scholar 

  9. Orth, J.D. & McNiven, M.A. Curr. Opin. Cell Biol. 15, 31–39 (2003).

    Article  CAS  Google Scholar 

  10. Thompson, H.M., Cao, H., Chen, J., Euteneuer, U. & McNiven, M.A. Nat. Cell Biol. 6, 335–342 (2004).

    Article  CAS  Google Scholar 

  11. Züchner, S. et al. Nat. Genet. 37, 289–294 (2005).

    Article  Google Scholar 

  12. Smirnova, E., Shurland, D.L., Newman-Smith, E.D., Pishvaee, B. & van der Bliek, A.M. J. Biol. Chem. 274, 14942–14947 (1999).

    Article  CAS  Google Scholar 

  13. Chen, Y.J., Zhang, P., Egelman, E.H. & Hinshaw, J.E. Nat. Struct. Mol. Biol. 11, 574–575 (2004).

    Article  CAS  Google Scholar 

  14. Tassin, A.M., Maro, B. & Bornens, M. J. Cell Biol. 100, 35–46 (1985).

    Article  CAS  Google Scholar 

  15. Reinsch, S. & Gonczy, P. J. Cell Sci. 111, 2283–2295 (1998).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the affected individuals and their families for their participation in this study, J.P. Leroy and J.L. Mandel for continuous support, E. Ralston for comments and suggestions on the manuscript, A. Rouche for assistance with immunohistochemistry and C. Lacroix for providing a DNA sample. This work was supported by the Institut National de la Santé et de la Recherche Médicale, the Centre National de la Recherche Scientifique, the Hôpital Universitaire de Strasbourg, the Collège de France and the Association Française contre les Myopathies. H.L. is member of the German Muscular Dystrophy Network supported by the German Ministry of Education and Research. P.-Y.J. was a recipient of a fellowship from the Swiss Foundation for Research on Muscle Diseases. A.H.B. was supported by a grant from the US National Institutes of Health and the Joshua Frase Foundation. M.B. was the recipient of an Association Française contre les Myopathies fellowship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pascale Guicheney.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

Phenotype and haplotype analysis of 3 autosomal dominant CNM families and DNM2 genotyping. (PDF 502 kb)

Supplementary Fig. 2

Physical map of the CNM locus and DNM2 mutations. (PDF 593 kb)

Supplementary Fig. 3

Predicted DNM2 structure and multiple protein alignment. (PDF 425 kb)

Supplementary Table 1

Cumulative two-point lod scores for chromosome 19p13 markers. (PDF 53 kb)

Supplementary Methods (PDF 38 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bitoun, M., Maugenre, S., Jeannet, PY. et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet 37, 1207–1209 (2005). https://doi.org/10.1038/ng1657

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng1657

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing